<div id="readability-page-1"><div><ul> <li>If you are wondering whether United States Antimony at US$8.61 still offers value after a huge run, the key is to separate price excitement from underlying worth.</li> <li>The stock is up 45.2% year to date and delivered 244.4% over the past year, even though it has fallen about 19.2% over the past week and about 19.5% over the past month.</li> <li>Those sharp recent moves can reflect shifting views on risk and opportunity, especially for a smaller materials stock where sentiment can change quickly.</li> <li>With a valuation score of 1 out of 6, the stock only screens as undervalued on one of six checks. Next comes a closer look at standard valuation approaches and, later in the article, a more complete way to think about what this price really implies.</li> </ul> <p>United States Antimony scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.</p> <h3>Approach 1: United States Antimony Discounted Cash Flow (DCF) Analysis</h3> <p>A Discounted Cash Flow model projects a company’s future cash flows and then discounts those projections back to today’s dollars to estimate what the business might be worth right now.</p> <p>For United States Antimony, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is a loss of $44.24 million. Analyst and extrapolated projections point to free cash flow of $65.00 million by 2030, with a path that includes both positive and negative years over the coming decade based on the supplied estimates and extensions.</p> <p>Pulling these cash flows together, Simply Wall St’s DCF model arrives at an estimated intrinsic value of about $6.21 per share. Compared with the recent share price of $8.61, this implies that the stock trades at a premium, with the DCF suggesting it is 38.7% overvalued at current levels.</p> <p><strong>Result: OVERVALUED</strong></p> <p>Our Discounted Cash Flow (DCF) analysis suggests United States Antimony may be overvalued by 38.7%. Discover 49 high quality undervalued stocks or create your own screener to find better value opportunities.</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7c376792-d6ed-4128-b81c-eda2e0d18ffb/chart/dcf/query-ZGF0ZT0yMDI2LTA1LTE2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7c376792-d6ed-4128-b81c-eda2e0d18ffb/chart/dcf/query-ZGF0ZT0yMDI2LTA1LTE2"/><figcaption>UAMY Discounted Cash Flow as at May 2026</figcaption></figure> <p>Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for United States Antimony.</p> <h3>Approach 2: United States Antimony Price vs Sales</h3> <p>For companies where earnings are limited or volatile, the P/S ratio can be a useful way to compare what investors are paying for each dollar of revenue. Higher growth expectations or lower perceived risk can support a higher “normal” P/S, while slower growth or higher risk usually calls for a lower one.</p> <p>United States Antimony currently trades on a P/S of 32.53x. This is well above the Metals and Mining industry average P/S of 2.49x and also above the peer group average of 7.69x that Simply Wall St uses for comparison.</p> <p>Simply Wall St’s Fair Ratio for United States Antimony is 5.93x. This is a proprietary estimate of what a reasonable P/S might be, given the company’s earnings profile, industry, profit margins, market capitalization and specific risks. It aims to be more tailored than a simple comparison with sector or peer averages, which do not adjust for those company specific factors.</p> <p>Comparing the Fair Ratio of 5.93x with the current P/S of 32.53x suggests the stock is trading well above what that framework would consider a more typical level.</p> <p><strong>Result: OVERVALUED</strong></p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7c376792-d6ed-4128-b81c-eda2e0d18ffb/chart/ps-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA1LTE2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7c376792-d6ed-4128-b81c-eda2e0d18ffb/chart/ps-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA1LTE2"/><figcaption>NYSE:UAMY P/S Ratio as at May 2026</figcaption></figure> <p>P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.</p> <h3>Upgrade Your Decision Making: Choose your United States Antimony Narrative</h3> <p>Earlier the article mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St’s Community page let you attach a clear story about United States Antimony to concrete numbers such as your assumed fair value, future revenue, earnings and margins. You can then compare that Fair Value with today’s price and see in real time how that story shifts when new earnings, news or project updates come through. This is why one investor may build a bullish narrative around a Fair Value close to US$13.50 per share, while another uses a more cautious view nearer US$9.00, even though both are looking at the same stock.</p> <p>Do you think there's more to the story for United States Antimony? Head over to our Community to see what others are saying!</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7c376792-d6ed-4128-b81c-eda2e0d18ffb/chart/quote-price/query-ZGF0ZT0yMDI2LTA1LTE2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7c376792-d6ed-4128-b81c-eda2e0d18ffb/chart/quote-price/query-ZGF0ZT0yMDI2LTA1LTE2"/><figcaption>NYSE:UAMY 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data         and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your         financial situation. We aim to bring you long-term focused analysis driven by fundamental data.         Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.         Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><div><p>• Dividend Powerhouses (3%+ Yield)<br/>• Undervalued Small Caps with Insider Buying<br/>• High growth Tech and AI Companies</p><p>Or build your own from over 50 metrics.</p></div><p>Explore Now for Free</p></div></div></div>

UAMY

<p>United States Antimony (UAMY) has surged 244% over the past year, currently priced at $8.61. Despite a year-to-date increase of 45.2%, it has recently fallen 19.2%. Valuation analysis indicates it is overvalued by 38.7% based on a Discounted Cash Flow model, with a fair value of $6.21 per share. The stock's Price-to-Sales ratio of 32.53x significantly exceeds industry averages, suggesting it trades well above typical levels.</p>

Is It Too Late To Consider United States Antimony (UAMY) After Its 244% One-Year Surge?